S3 Ep60: Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Data presented during the 2023 Gastrointestinal Cancers Symposium have accentuated the amount of ongoing research across many of these hard-to-treat gastrointestinal malignancies, according to Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC. Specifically, data surrounding the utility of circulating tumor…
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss …
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss …
AI Data Centres, Affordable Dating & Pancreatic Cancer Breakthroughs
In this week's episode of the Your Morning Podcast, we dive into the biggest stories shaping Canada today, from the front lines of tech and health to the evolving landscape of modern dating. First, technology analyst Daniel Bader explains why opposition is mounting against AI data centres across th…
MATTERHORN Roundtable: Perioperative FLOT & Immunotherapy Updates in Gastric Cancer
The treatment landscape for perioperative gastric cancer is changing rapidly.
In this expert roundtable, leading GI oncology specialists discuss the practice-changing impact of the MATTERHORN trial, the role of immunotherapy in resectable gastric cancer, and how emerging data from ASCO 2026 is inf…
Promising new treatments for pancreatic cancer and ALS
Pancreatic cancer is among the most deadly forms of cancer, and it can be difficult to catch early. But there’s some good news: Clinical trials of a new drug called daraxonrasib found that it doubled the survival time of patients with advanced pancreatic cancer. And some oncologists are calling it …
Targeting TROP2 in Oncology: Pan-Tumor Insights and the Next Wave of ADC Innovation
Please visit answersincme.com/NHB860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Zev Wainberg, MD. In this activity, an expert in oncology discusses the use of TROP2-directed antibody-drug conjugates (ADCs) across solid tumor…
Targeting TROP2 in Oncology: Pan-Tumor Insights and the Next Wave of ADC Innovation
Please visit answersincme.com/NHB860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Zev Wainberg, MD. In this activity, an expert in oncology discusses the use of TROP2-directed antibody-drug conjugates (ADCs) across solid tumor…
Targeting TROP2 in Oncology: Pan-Tumor Insights and the Next Wave of ADC Innovation
Please visit answersincme.com/NHB860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Zev Wainberg, MD. In this activity, an expert in oncology discusses the use of TROP2-directed antibody-drug conjugates (ADCs) across solid tumor…
Targeting TROP2 in Oncology: Pan-Tumor Insights and the Next Wave of ADC Innovation
Please visit answersincme.com/NHB860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Zev Wainberg, MD. In this activity, an expert in oncology discusses the use of TROP2-directed antibody-drug conjugates (ADCs) across solid tumor…
पॉडकास्ट खोज इंजन
आप लोगों, स्थानों या विषयों के आधार पर3,825,280पॉडकास्ट और195,819,548एपिसोड खोजने के लिए हमारी वेबसाइट का उपयोग कर सकते हैं।
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
संपादित करें
पॉडकास्ट डेटाबेस को अपडेटेड रखने में मदद के लिए धन्यवाद।
